We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-13.46%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.65%
AUM
$161B
AUM Growth
-$27.5B
Cap. Flow
+$7.94B
Cap. Flow %
4.93%
Top 10 Hldgs %
22.83%
Holding
7,971
New
1,144
Increased
2,588
Reduced
2,287
Closed
1,065

Top Sells

Rank Stock Value
1
CERN
Cerner Corp
CERN
+$517M
2
XOM icon
ExxonMobil
XOM
+$385M
3
CVE icon
Cenovus Energy
CVE
+$292M
4
PLAN
Anaplan, Inc.
PLAN
+$236M
5
PSX icon
Phillips 66
PSX
+$222M

Sector Composition

Rank Sector Weight
1 Technology 7.76%
2 Financials 7.62%
3 Healthcare 7.1%
4 Industrials 5.08%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MITO
6626
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$10K ﹤0.01%
41,517
+2,958
+8% +$1.02K
GAPA.WS
6627
CALL
DELISTED
G&P Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
GAPA.WS
$10K ﹤0.01%
113,241
CRU.WS
6628
CALL
DELISTED
Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CRU.WS
$10K ﹤0.01%
98,333
EVGN icon
6629
Evogene
EVGN
$7.26M
$9K ﹤0.01%
1,167
-8,127
-87% -$79.5K
INBS icon
6630
Intelligent Bio Solutions
INBS
$4.74M
$9K ﹤0.01%
6
-6
-50% -$10.1K
LDTCW
6631
CALL
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
$9K ﹤0.01%
76,666
MYND
6632
Mynd.ai
MYND
$19.3M
$9K ﹤0.01%
+1,502
New +$11.5K
SLNO
6633
DELISTED
Soleno Therapeutics
SLNO
$9K ﹤0.01%
+3,088
New +$8.55K
SNGX icon
6634
Soligenix
SNGX
$5.81M
$9K ﹤0.01%
61
+6
+11% +$829
TOMZ icon
6635
TOMI Environmental Solutions
TOMZ
$14M
$9K ﹤0.01%
+4,081
New +$9.98K
BRLSW icon
6636
CALL
Borealis Foods Inc Warrant
BRLSW
$9K ﹤0.01%
85,828
FAASW
6637
CALL
DELISTED
DigiAsia Corp Warrant
FAASW
$9K ﹤0.01%
125,000
WINVW
6638
CALL
DELISTED
WinVest Acquisition Corp. Warrant
WINVW
$9K ﹤0.01%
100,000
EVE.WS
6639
CALL
DELISTED
EVe Mobility Acquisition Corp Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EVE.WS
$9K ﹤0.01%
+95,500
New +$19K
WEL.WS
6640
CALL
DELISTED
Integrated Wellness Acquisition Corp Redeemable Warrants
WEL.WS
$9K ﹤0.01%
+52,500
New +$13.2K
CLDI.WS
6641
CALL
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$9K ﹤0.01%
100,000
AAGRW
6642
CALL
DELISTED
African Agriculture Holdings Inc Warrant
AAGRW
$9K ﹤0.01%
66,666
HGASW
6643
CALL
DELISTED
Global Gas Corporation Warrant
HGASW
$9K ﹤0.01%
189,897
IRRX.WS
6644
CALL
DELISTED
Integrated Rail and Resources Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
IRRX.WS
$9K ﹤0.01%
30,000
OHAAW
6645
CALL
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$9K ﹤0.01%
36,700
BODY.WS
6646
CALL
DELISTED
The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
BODY.WS
$9K ﹤0.01%
55,083
BIOSW
6647
CALL
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$9K ﹤0.01%
+67,500
New +$12.6K
BLNGW
6648
CALL
DELISTED
Belong Acquisition Corp. Warrant
BLNGW
$9K ﹤0.01%
83,750
WRAC.WS
6649
CALL
DELISTED
Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
WRAC.WS
$9K ﹤0.01%
100,000
BNNRW
6650
CALL
DELISTED
Banner Acquisition Corp. Warrants
BNNRW
$9K ﹤0.01%
83,600

Similar funds

Millennium Management's Q2 2022 Portfolio in Review

As of Q2 2022, Millennium Management held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Millennium Management deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.

  • Millennium Management's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
  • Millennium Management added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
  • Millennium Management's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
  • Millennium Management fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
  • Millennium Management's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
  • Millennium Management opened 1,144 new positions and closed 1,065 in Q2 2022.
  • Millennium Management's portfolio value fell 15% quarter-over-quarter to $161B.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.